Is Your Quality System Ready for EU Expansion?
UK life sciences companies scaling into EU markets face a critical inflection point: the processes, governance structures, and oversight mechanisms that worked locally rarely hold up under cross-border scrutiny. This Webinar shows you exactly how to close that gap, before regulators or partners find it first.
What you’ll learn:
- How to meet MHRA and EU regulator expectations for cross-border control. Understand what inspectors and partners look for when assessing governance maturity in internationally expanding organizations, and how to demonstrate readiness with confidence.
- How to build a connected quality loop that holds up at every site. Link quality events, CAPAs, change controls, SOPs, and training into a single, traceable system, so nothing falls through the gaps when your operations grow.
- How to scale quality governance internationally without the common pitfalls. Identify the visibility gaps, process fragmentation, and ownership ambiguities that derail most scale-ups, and put the right structures in place before they cost you.
Speakers
- Alex Pagès: QMS Consulting Line Director at Rephine
- Angel Buendia: Knowledge Manager at Scilife
- Jordi Ametller: Senior Account Executive at Scilife
Complete the form to watch the full Webinar and strengthen your inspection readiness across UK and EU markets.
Watch the Webinar
View our other resources and company news
- White Paper
Is your quality dashboard testing anything, or just showing green? A practical guide to KPIs and dashboards that surface risk early enough to act on...
- Case Study
A mid-sized pharmaceutical company embarked on a three-year digital transformation to validate TrackWise Digital across three sequential phases. See how full operational support within ValGenesis...
- Article
As regulatory demands grow, even strong QA teams reach their limits. Here is how flexible QA support helps pharmaceutical companies manage change, reduce risk and...
- Article
Rephine Barcelona S.L. is now accredited to ISO/IEC 17020 as an inspection body for specific GMP and GDP audit activities. We explain what the accreditation...
- White Paper
Relying on historical cleaning limits or visual cleanliness checks to justify shared manufacturing carries more regulatory risk than many sites realise. Find out what a...
- Article
Every change to a validated system carries risk. Discover the core components, roles and best practices that keep Change Management in CSV projects controlled, compliant...
- Case Study
A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full...
- White Paper
Turn data integrity findings into a sustainable, risk based remediation plan. A practical 7 phase framework for pharma labs....
- Article
Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide...
